Joseph Driscoll

Chief Financial Officer, Summer Infant, Inc.

Companies

Akoya Biosciences, Inc.Chief financial officer Apr 20, 2021 to Dec 27, 2022¹
Quanterix (United States)Chief financial officer Dec 6, 2017 to Jan 15, 2019²
PC ConnectionChief financial officer Mar 6, 2012 to Sep 2, 2016³
Summer Infant, Inc.Chief financial officer Mar 8, 2007 to Dec 13, 2011⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Akoya Biosciences, Inc.262,500 shares⁵Dec 22, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 22, 2022Exercised options 250,000 shares at $0.44 of Akoya Biosciences, Inc.⁵
Dec 14, 2022Sold 14,574 shares at $12.46 of Akoya Biosciences, Inc.⁶
Dec 14, 2022Exercised options 14,574 shares at $0.44 of Akoya Biosciences, Inc.⁶
Dec 14, 2022Sold 10,039 shares at $12.67 of Akoya Biosciences, Inc.⁶
Dec 14, 2022Exercised options 10,039 shares at $0.44 of Akoya Biosciences, Inc.⁶
Mar 23, 2022Granted 12,500 shares of Akoya Biosciences, Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAkoya Biosciences, Inc., Chief financial officer
2
SEC EDGARQuanterix (United States), Chief financial officer
3
SEC EDGARPC Connection, Chief financial officer
4
SEC EDGARSummer Infant, Inc., Chief financial officer
5
SEC EDGARAkoya Biosciences, Inc. shares after the filing of Dec 22, 2022
6
SEC EDGARForm 4 filed Dec 16, 2022
7
SEC EDGARForm 4 filed Mar 25, 2022